Last reviewed · How we verify

NCT03535454

Work-Related Fibromyalgia

Completed Last updated 12 October 2018
What this trial tests

trial testing working hours in Fibromyalgia, Secondary in 110 participants. Completed in 11 October 2018.

Timeline
1 March 2018
Primary endpoint
1 September 2018
11 October 2018

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date1 March 2018
Primary completion1 September 2018
Estimated completion11 October 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 65, female only, with Fibromyalgia, Secondary. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research is about fibromyalgia prevalency in working population and searching work-related fibromyalgia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Decreased Chronic Widespread Pain on Nonworking Days Might Help Differentiate Work-Related Musculoskeletal Disorders From Fibromyalgia: A Cross-Sectional Study of Working Females.
    Güler MA, Çakit MO. · · 2020 · cited 1× · PMID 33758805 · DOI 10.46497/archrheumatol.2020.7683

Verify or expand the search:

Other recruiting trials for Fibromyalgia, Secondary

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03535454.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing